APO Research
Talk to an analyst

APO RESEARCH · REPORT

Preventive Vaccines

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Preventive Vaccines Industry Growth and Trends Forecast to 2032

22 December 202593 pages

Choose your research edition.

Industry ResearchPreventive Vaccines Industry Research Report 2026118 pages · $2,950 USDIndustry Growth & TrendsGlobal Preventive Vaccines Industry Growth and Trends Forecast to 203293 pages · $3,450 USDMarket StructureGlobal Preventive Vaccines Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032188 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Preventive Vaccines Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal Preventive Vaccines Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global Preventive Vaccines market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Preventive Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Preventive Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Preventive Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Preventive Vaccines include Abbott, Sanofi, GlaxoSmithKline, AstraZeneca, Serum Institute of India and CSL Ltd, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Preventive Vaccines market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Preventive Vaccines market size, estimates, and forecasts are presented in terms of sales volume (doses) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Preventive Vaccines market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Preventive Vaccines.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Preventive Vaccines market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Preventive Vaccines Market by Company

Abbott

Sanofi

GlaxoSmithKline

AstraZeneca

Serum Institute of India

CSL Ltd

Preventive Vaccines Segment by Type

Intradermal Shot

Intramuscular Injection

Nasal Spray

Preventive Vaccines Segment by Application

Hospital

Clinic

Other

Preventive Vaccines Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Preventive Vaccines market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Preventive Vaccines and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Preventive Vaccines.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Preventive Vaccines manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Preventive Vaccines in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Intradermal Shot Table 2. Major Company of Intramuscular Injection Table 3. Major Company of Nasal Spray Table 4. Global Preventive Vaccines Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Preventive Vaccines Sales by Type (2021-2026) & (doses) Table 6. Global Preventive Vaccines Sales Market Share in Volume by Type (2021-2026) Table 7. Global Preventive Vaccines Sales by Type (2021-2026) & (US$ Million) Table 8. Global Preventive Vaccines Sales Market Share in Value by Type (2021-2026) Table 9. Global Preventive Vaccines Price by Type (2021-2026) & (US$/dose) Table 10. Global Preventive Vaccines Sales by Type (2027-2032) & (doses) Table 11. Global Preventive Vaccines Sales Market Share in Volume by Type (2027-2032) Table 12. Global Preventive Vaccines Sales by Type (2027-2032) & (US$ Million) Table 13. Global Preventive Vaccines Sales Market Share in Value by Type (2027-2032) Table 14. Global Preventive Vaccines Price by Type (2027-2032) & (US$/dose) Table 15. North America Preventive Vaccines Sales by Type (2021-2026) & (doses) Table 16. North America Preventive Vaccines Sales by Type (2021-2026) & (US$ Million) Table 17. Europe Preventive Vaccines Sales by Type (2021-2026) & (doses) Table 18. Europe Preventive Vaccines Sales by Type (2021-2026) & (US$ Million) Table 19. Asia-Pacific Preventive Vaccines Sales by Type (2021-2026) & (doses) Table 20. Asia-Pacific Preventive Vaccines Sales by Type (2021-2026) & (US$ Million) Table 21. Latin America Preventive Vaccines Sales by Type (2021-2026) & (doses) Table 22. Latin America Preventive Vaccines Sales by Type (2021-2026) & (US$ Million) Table 23. Middle East and Africa Preventive Vaccines Sales by Type (2021-2026) & (doses) Table 24. Middle East and Africa Preventive Vaccines Sales by Type (2021-2026) & (US$ Million) Table 25. Preventive Vaccines Industry Trends Table 26. Preventive Vaccines Industry Drivers Table 27. Preventive Vaccines Industry Opportunities and Challenges Table 28. Preventive Vaccines Industry Restraints Table 29. Global Preventive Vaccines Sales Revenue by Company (US$ Million) & (2021-2026) Table 30. Global Preventive Vaccines Revenue Market Share by Company (2021-2026) Table 31. Global Preventive Vaccines Sales by Company (2021-2026) & (doses) Table 32. Global Preventive Vaccines Sales Share by Company (2021-2026) Table 33. Global Preventive Vaccines Market Price by Company (2021-2026) & (US$/dose) Table 34. Global Preventive Vaccines Industry Company Ranking, 2024 VS 2025 VS 2026 Table 35. Global Preventive Vaccines Major Company Production Sites and Headquarters Table 36. Global Preventive Vaccines Company, Product Type & Application Table 37. Global Preventive Vaccines Company Establishment Date Table 38. Global Company Market Concentration Ratio (CR5 and HHI) Table 39. Global Preventive Vaccines by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 40. Global Preventive Vaccines Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 41. Global Preventive Vaccines Sales by Region (2021-2026) & (doses) Table 42. Global Preventive Vaccines Sales Market Share in Volume by Region (2021-2026) Table 43. Global Preventive Vaccines Sales by Region (2021-2026) & (US$ Million) Table 44. Global Preventive Vaccines Sales Market Share in Value by Region (2021-2026) Table 45. Global Preventive Vaccines Sales (doses), Value (US$ Million), Price (US$/dose) and Gross Margin (2021-2026) Table 46. Global Preventive Vaccines Sales by Region (2027-2032) & (doses) Table 47. Global Preventive Vaccines Sales Market Share in Volume by Region (2027-2032) Table 48. Global Preventive Vaccines Sales by Region (2027-2032) & (US$ Million) Table 49. Global Preventive Vaccines Sales Market Share in Value by Region (2027-2032) Table 50. Global Preventive Vaccines Sales (doses), Value (US$ Million), Price (US$/dose) and Gross Margin (2027-2032) Table 51. Global Preventive Vaccines Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 52. Global Preventive Vaccines Sales by Application (2021-2026) & (doses) Table 53. Global Preventive Vaccines Sales Market Share in Volume by Application (2021-2026) Table 54. Global Preventive Vaccines Sales by Application (2021-2026) & (US$ Million) Table 55. Global Preventive Vaccines Sales Market Share in Value by Application (2021-2026) Table 56. Global Preventive Vaccines Price by Application (2021-2026) & (US$/dose) Table 57. Global Preventive Vaccines Sales by Application (2027-2032) & (doses) Table 58. Global Preventive Vaccines Sales Market Share in Volume by Application (2027-2032) Table 59. Global Preventive Vaccines Sales by Application (2027-2032) & (US$ Million) Table 60. Global Preventive Vaccines Sales Market Share in Value by Application (2027-2032) Table 61. Global Preventive Vaccines Price by Application (2027-2032) & (US$/dose) Table 62. North America Preventive Vaccines Sales by Application (2021-2026) & (doses) Table 63. North America Preventive Vaccines Sales by Application (2021-2026) & (US$ Million) Table 64. Europe Preventive Vaccines Sales by Application (2021-2026) & (doses) Table 65. Europe Preventive Vaccines Sales by Application (2021-2026) & (US$ Million) Table 66. Asia-Pacific Preventive Vaccines Sales by Application (2021-2026) & (doses) Table 67. Asia-Pacific Preventive Vaccines Sales by Application (2021-2026) & (US$ Million) Table 68. Latin America Preventive Vaccines Sales by Application (2021-2026) & (doses) Table 69. Latin America Preventive Vaccines Sales by Application (2021-2026) & (US$ Million) Table 70. Middle East and Africa Preventive Vaccines Sales by Application (2021-2026) & (doses) Table 71. Middle East and Africa Preventive Vaccines Sales by Application (2021-2026) & (US$ Million) Table 72. Abbott Company Information Table 73. Abbott Business Overview Table 74. Abbott Preventive Vaccines Sales (doses), Revenue (US$ Million), Price (US$/dose) and Gross Margin (2021-2026) Table 75. Abbott Preventive Vaccines Product Portfolio Table 76. Abbott Recent Development Table 77. Sanofi Company Information Table 78. Sanofi Business Overview Table 79. Sanofi Preventive Vaccines Sales (doses), Revenue (US$ Million), Price (US$/dose) and Gross Margin (2021-2026) Table 80. Sanofi Preventive Vaccines Product Portfolio Table 81. Sanofi Recent Development Table 82. GlaxoSmithKline Company Information Table 83. GlaxoSmithKline Business Overview Table 84. GlaxoSmithKline Preventive Vaccines Sales (doses), Revenue (US$ Million), Price (US$/dose) and Gross Margin (2021-2026) Table 85. GlaxoSmithKline Preventive Vaccines Product Portfolio Table 86. GlaxoSmithKline Recent Development Table 87. AstraZeneca Company Information Table 88. AstraZeneca Business Overview Table 89. AstraZeneca Preventive Vaccines Sales (doses), Revenue (US$ Million), Price (US$/dose) and Gross Margin (2021-2026) Table 90. AstraZeneca Preventive Vaccines Product Portfolio Table 91. AstraZeneca Recent Development Table 92. Serum Institute of India Company Information Table 93. Serum Institute of India Business Overview Table 94. Serum Institute of India Preventive Vaccines Sales (doses), Revenue (US$ Million), Price (US$/dose) and Gross Margin (2021-2026) Table 95. Serum Institute of India Preventive Vaccines Product Portfolio Table 96. Serum Institute of India Recent Development Table 97. CSL Ltd Company Information Table 98. CSL Ltd Business Overview Table 99. CSL Ltd Preventive Vaccines Sales (doses), Revenue (US$ Million), Price (US$/dose) and Gross Margin (2021-2026) Table 100. CSL Ltd Preventive Vaccines Product Portfolio Table 101. CSL Ltd Recent Development Table 102. North America Preventive Vaccines Market Size Growth Rate (CAGR) by Country (doses): 2021 VS 2025 VS 2032 Table 103. North America Preventive Vaccines Sales by Country (2021-2026) & (doses) Table 104. North America Preventive Vaccines Sales Market Share by Country (2021-2026) Table 105. North America Preventive Vaccines Sales Forecast by Country (2027-2032) & (doses) Table 106. North America Preventive Vaccines Sales Market Share Forecast by Country (2027-2032) Table 107. North America Preventive Vaccines Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 108. North America Preventive Vaccines Market Size by Country (2021-2026) & (US$ Million) Table 109. North America Preventive Vaccines Market Share by Country (2021-2026) Table 110. North America Preventive Vaccines Market Size Forecast by Country (2027-2032) & (US$ Million) Table 111. North America Preventive Vaccines Market Share Forecast by Country (2027-2032) Table 112. Europe Preventive Vaccines Market Size Growth Rate (CAGR) by Country (doses): 2021 VS 2025 VS 2032 Table 113. Europe Preventive Vaccines Sales by Country (2021-2026) & (doses) Table 114. Europe Preventive Vaccines Sales Market Share by Country (2021-2026) Table 115. Europe Preventive Vaccines Sales Forecast by Country (2027-2032) & (doses) Table 116. Europe Preventive Vaccines Sales Market Share Forecast by Country (2027-2032) Table 117. Europe Preventive Vaccines Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 118. Europe Preventive Vaccines Market Size by Country (2021-2026) & (US$ Million) Table 119. Europe Preventive Vaccines Market Share by Country (2021-2026) Table 120. Europe Preventive Vaccines Market Size Forecast by Country (2027-2032) & (US$ Million) Table 121. Europe Preventive Vaccines Market Share Forecast by Country (2027-2032) Table 122. Asia-Pacific Preventive Vaccines Market Size Growth Rate (CAGR) by Country (doses): 2021 VS 2025 VS 2032 Table 123. Asia-Pacific Preventive Vaccines Sales by Country (2021-2026) & (doses) Table 124. Asia-Pacific Preventive Vaccines Sales Market Share by Country (2021-2026) Table 125. Asia-Pacific Preventive Vaccines Sales Forecast by Country (2027-2032) & (doses) Table 126. Asia-Pacific Preventive Vaccines Sales Market Share Forecast by Country (2027-2032) Table 127. Asia-Pacific Preventive Vaccines Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 128. Asia-Pacific Preventive Vaccines Market Size by Country (2021-2026) & (US$ Million) Table 129. Asia-Pacific Preventive Vaccines Market Share by Country (2021-2026) Table 130. Asia-Pacific Preventive Vaccines Market Size Forecast by Country (2027-2032) & (US$ Million) Table 131. Asia-Pacific Preventive Vaccines Market Share Forecast by Country (2027-2032) Table 132. Latin America Preventive Vaccines Market Size Growth Rate (CAGR) by Country (doses): 2021 VS 2025 VS 2032 Table 133. Latin America Preventive Vaccines Sales by Country (2021-2026) & (doses) Table 134. Latin America Preventive Vaccines Sales Market Share by Country (2021-2026) Table 135. Latin America Preventive Vaccines Sales Forecast by Country (2027-2032) & (doses) Table 136. Latin America Preventive Vaccines Sales Market Share Forecast by Country (2027-2032) Table 137. Latin America Preventive Vaccines Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 138. Latin America Preventive Vaccines Market Size by Country (2021-2026) & (US$ Million) Table 139. Latin America Preventive Vaccines Market Share by Country (2021-2026) Table 140. Latin America Preventive Vaccines Market Size Forecast by Country (2027-2032) & (US$ Million) Table 141. Latin America Preventive Vaccines Market Share Forecast by Country (2027-2032) Table 142. Middle East and Africa Preventive Vaccines Market Size Growth Rate (CAGR) by Country (doses): 2021 VS 2025 VS 2032 Table 143. Middle East and Africa Preventive Vaccines Sales by Country (2021-2026) & (doses) Table 144. Middle East and Africa Preventive Vaccines Sales Market Share by Country (2021-2026) Table 145. Middle East and Africa Preventive Vaccines Sales Forecast by Country (2027-2032) & (doses) Table 146. Middle East and Africa Preventive Vaccines Sales Market Share Forecast by Country (2027-2032) Table 147. Middle East and Africa Preventive Vaccines Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 148. Middle East and Africa Preventive Vaccines Market Size by Country (2021-2026) & (US$ Million) Table 149. Middle East and Africa Preventive Vaccines Market Share by Country (2021-2026) Table 150. Middle East and Africa Preventive Vaccines Market Size Forecast by Country (2027-2032) & (US$ Million) Table 151. Middle East and Africa Preventive Vaccines Market Share Forecast by Country (2027-2032) Table 152. Key Raw Materials Table 153. Raw Materials Key Suppliers Table 154. Preventive Vaccines Distributors List Table 155. Preventive Vaccines Customers List Table 156. Research Programs/Design for This Report Table 157. Authors List of This Report Table 158. Secondary Sources Table 159. Primary Sources List of Figures Figure 1. Preventive Vaccines Image Figure 2. Global Preventive Vaccines Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Preventive Vaccines Market Size (2021-2032) & (US$ Million) Figure 4. Global Preventive Vaccines Sales (2021-2032) & (doses) Figure 5. Intradermal Shot Image Figure 6. Global Intradermal Shot Sales YoY Growth (2021-2032) & (doses) Figure 7. Intramuscular Injection Image Figure 8. Global Intramuscular Injection Sales YoY Growth (2021-2032) & (doses) Figure 9. Nasal Spray Image Figure 10. Global Nasal Spray Sales YoY Growth (2021-2032) & (doses) Figure 11. Global Preventive Vaccines Market Size Overview by Type (2021-2032) & (US$ Million) Figure 12. Global Preventive Vaccines Market Share by Type 2025 VS 2032 Figure 13. North America Preventive Vaccines Sales Market Share in Volume by Type in 2025 Figure 14. North America Preventive Vaccines Sales Market Share in Value by Type in 2025 Figure 15. Europe Preventive Vaccines Sales Market Share in Volume by Type in 2025 Figure 16. Europe Preventive Vaccines Sales Market Share in Value by Type in 2025 Figure 17. Asia-Pacific Preventive Vaccines Sales Market Share in Volume by Type in 2025 Figure 18. Asia-Pacific Preventive Vaccines Sales Market Share in Value by Type in 2025 Figure 19. Latin America Preventive Vaccines Sales Market Share in Volume by Type in 2025 Figure 20. Latin America Preventive Vaccines Sales Market Share in Value by Type in 2025 Figure 21. Middle East and Africa Preventive Vaccines Sales Market Share in Volume by Type in 2025 Figure 22. Middle East and Africa Preventive Vaccines Sales Market Share in Value by Type in 2025 Figure 23. Global Top 5 and 10 Preventive Vaccines Players Market Share by Revenue in 2025 Figure 24. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 25. Hospital Image Figure 26. Global Hospital Sales YoY Growth (2021-2032) & (doses) Figure 27. Clinic Image Figure 28. Global Clinic Sales YoY Growth (2021-2032) & (doses) Figure 29. Other Image Figure 30. Global Other Sales YoY Growth (2021-2032) & (doses) Figure 31. Global Preventive Vaccines Market Size Overview by Application (2021-2032) & (US$ Million) Figure 32. Global Preventive Vaccines Market Share by Application 2025 VS 2032 Figure 33. North America Preventive Vaccines Sales Market Share in Volume by Application in 2025 Figure 34. North America Preventive Vaccines Sales Market Share in Value by Application in 2025 Figure 35. Europe Preventive Vaccines Sales Market Share in Volume by Application in 2025 Figure 36. Europe Preventive Vaccines Sales Market Share in Value by Application in 2025 Figure 37. Asia-Pacific Preventive Vaccines Sales Market Share in Volume by Application in 2025 Figure 38. Asia-Pacific Preventive Vaccines Sales Market Share in Value by Application in 2025 Figure 39. Latin America Preventive Vaccines Sales Market Share in Volume by Application in 2025 Figure 40. Latin America Preventive Vaccines Sales Market Share in Value by Application in 2025 Figure 41. Middle East and Africa Preventive Vaccines Sales Market Share in Volume by Application in 2025 Figure 42. Middle East and Africa Preventive Vaccines Sales Market Share in Value by Application in 2025 Figure 43. North America Preventive Vaccines Sales by Country: 2021 VS 2025 VS 2032 (doses) Figure 44. North America Preventive Vaccines Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. North America Preventive Vaccines Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. North America Preventive Vaccines Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Preventive Vaccines Sales by Country: 2021 VS 2025 VS 2032 (doses) Figure 48. Europe Preventive Vaccines Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Preventive Vaccines Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Europe Preventive Vaccines Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Preventive Vaccines Sales by Country: 2021 VS 2025 VS 2032 (doses) Figure 52. Asia-Pacific Preventive Vaccines Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Preventive Vaccines Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Asia-Pacific Preventive Vaccines Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Preventive Vaccines Sales by Country: 2021 VS 2025 VS 2032 (doses) Figure 56. Latin America Preventive Vaccines Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Preventive Vaccines Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Latin America Preventive Vaccines Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Preventive Vaccines Sales by Country: 2021 VS 2025 VS 2032 (doses) Figure 60. Middle East and Africa Preventive Vaccines Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Preventive Vaccines Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Middle East and Africa Preventive Vaccines Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Preventive Vaccines Value Chain Figure 64. Key Raw Materials Price Figure 65. Manufacturing Cost Structure Figure 66. Preventive Vaccines Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Intradermal Shot
  • Intramuscular Injection
  • Nasal Spray
Applications
  • Hospital
  • Clinic
  • Other
Companies covered
  • Abbott
  • Sanofi
  • GlaxoSmithKline
  • AstraZeneca
  • Serum Institute of India
  • CSL Ltd

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Preventive Vaccines Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Preventive Vaccines Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Preventive Vaccines Market by Type
  6. 1.3.1 Intradermal Shot
  7. 1.3.2 Intramuscular Injection
  8. 1.3.3 Nasal Spray
  9. 1.4 Global Preventive Vaccines Market Size by Type
  10. 1.4.1 Global Preventive Vaccines Market Size Overview by Type (2021-2032)
  11. 1.4.2 Global Preventive Vaccines Historic Market Size Review by Type (2021-2026)
  12. 1.4.3 Global Preventive Vaccines Forecasted Market Size by Type (2027-2032)
  13. 1.5 Key Regions Market Size by Type
  14. 1.5.1 North America Preventive Vaccines Sales Breakdown by Type (2021-2026)
  15. 1.5.2 Europe Preventive Vaccines Sales Breakdown by Type (2021-2026)
  16. 1.5.3 Asia-Pacific Preventive Vaccines Sales Breakdown by Type (2021-2026)
  17. 1.5.4 South America Preventive Vaccines Sales Breakdown by Type (2021-2026)
  18. 1.5.5 Middle East and Africa Preventive Vaccines Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Preventive Vaccines Industry Trends
  2. 2.2 Preventive Vaccines Industry Drivers
  3. 2.3 Preventive Vaccines Industry Opportunities and Challenges
  4. 2.4 Preventive Vaccines Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Preventive Vaccines Revenue (2021-2026)
  2. 3.2 Global Top Players by Preventive Vaccines Sales (2021-2026)
  3. 3.3 Global Top Players by Preventive Vaccines Price (2021-2026)
  4. 3.4 Global Preventive Vaccines Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Preventive Vaccines Major Company Production Sites & Headquarters
  6. 3.6 Global Preventive Vaccines Company, Product Type & Application
  7. 3.7 Global Preventive Vaccines Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Preventive Vaccines Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Preventive Vaccines Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Preventive Vaccines Tier 1, Tier 2, and Tier 3
4 Preventive Vaccines Regional Status and Outlook
  1. 4.1 Global Preventive Vaccines Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Preventive Vaccines Historic Market Size by Region
  3. 4.2.1 Global Preventive Vaccines Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Preventive Vaccines Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Preventive Vaccines Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Preventive Vaccines Forecasted Market Size by Region
  7. 4.3.1 Global Preventive Vaccines Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Preventive Vaccines Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Preventive Vaccines Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Preventive Vaccines by Application
  1. 5.1 Preventive Vaccines Market by Application
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.1.3 Other
  5. 5.2 Global Preventive Vaccines Market Size by Application
  6. 5.2.1 Global Preventive Vaccines Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Preventive Vaccines Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Preventive Vaccines Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Preventive Vaccines Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Preventive Vaccines Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Preventive Vaccines Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Preventive Vaccines Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Preventive Vaccines Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Abbott
  2. 6.1.1 Abbott Company Information
  3. 6.1.2 Abbott Business Overview
  4. 6.1.3 Abbott Preventive Vaccines Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Abbott Preventive Vaccines Product Portfolio
  6. 6.1.5 Abbott Recent Developments
  7. 6.2 Sanofi
  8. 6.2.1 Sanofi Company Information
  9. 6.2.2 Sanofi Business Overview
  10. 6.2.3 Sanofi Preventive Vaccines Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Sanofi Preventive Vaccines Product Portfolio
  12. 6.2.5 Sanofi Recent Developments
  13. 6.3 GlaxoSmithKline
  14. 6.3.1 GlaxoSmithKline Company Information
  15. 6.3.2 GlaxoSmithKline Business Overview
  16. 6.3.3 GlaxoSmithKline Preventive Vaccines Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 GlaxoSmithKline Preventive Vaccines Product Portfolio
  18. 6.3.5 GlaxoSmithKline Recent Developments
  19. 6.4 AstraZeneca
  20. 6.4.1 AstraZeneca Company Information
  21. 6.4.2 AstraZeneca Business Overview
  22. 6.4.3 AstraZeneca Preventive Vaccines Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 AstraZeneca Preventive Vaccines Product Portfolio
  24. 6.4.5 AstraZeneca Recent Developments
  25. 6.5 Serum Institute of India
  26. 6.5.1 Serum Institute of India Company Information
  27. 6.5.2 Serum Institute of India Business Overview
  28. 6.5.3 Serum Institute of India Preventive Vaccines Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Serum Institute of India Preventive Vaccines Product Portfolio
  30. 6.5.5 Serum Institute of India Recent Developments
  31. 6.6 CSL Ltd
  32. 6.6.1 CSL Ltd Company Information
  33. 6.6.2 CSL Ltd Business Overview
  34. 6.6.3 CSL Ltd Preventive Vaccines Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 CSL Ltd Preventive Vaccines Product Portfolio
  36. 6.6.5 CSL Ltd Recent Developments
7 North America by Country
  1. 7.1 North America Preventive Vaccines Sales by Country
  2. 7.1.1 North America Preventive Vaccines Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Preventive Vaccines Sales by Country (2021-2026)
  4. 7.1.3 North America Preventive Vaccines Sales Forecast by Country (2027-2032)
  5. 7.2 North America Preventive Vaccines Market Size by Country
  6. 7.2.1 North America Preventive Vaccines Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Preventive Vaccines Market Size by Country (2021-2026)
  8. 7.2.3 North America Preventive Vaccines Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Preventive Vaccines Sales by Country
  2. 8.1.1 Europe Preventive Vaccines Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Preventive Vaccines Sales by Country (2021-2026)
  4. 8.1.3 Europe Preventive Vaccines Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Preventive Vaccines Market Size by Country
  6. 8.2.1 Europe Preventive Vaccines Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Preventive Vaccines Market Size by Country (2021-2026)
  8. 8.2.3 Europe Preventive Vaccines Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Preventive Vaccines Sales by Country
  2. 9.1.1 Asia-Pacific Preventive Vaccines Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Preventive Vaccines Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Preventive Vaccines Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Preventive Vaccines Market Size by Country
  6. 9.2.1 Asia-Pacific Preventive Vaccines Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Preventive Vaccines Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Preventive Vaccines Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Preventive Vaccines Sales by Country
  2. 10.1.1 South America Preventive Vaccines Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Preventive Vaccines Sales by Country (2021-2026)
  4. 10.1.3 South America Preventive Vaccines Sales Forecast by Country (2027-2032)
  5. 10.2 South America Preventive Vaccines Market Size by Country
  6. 10.2.1 South America Preventive Vaccines Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Preventive Vaccines Market Size by Country (2021-2026)
  8. 10.2.3 South America Preventive Vaccines Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Preventive Vaccines Sales by Country
  2. 11.1.1 Middle East and Africa Preventive Vaccines Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Preventive Vaccines Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Preventive Vaccines Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Preventive Vaccines Market Size by Country
  6. 11.2.1 Middle East and Africa Preventive Vaccines Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Preventive Vaccines Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Preventive Vaccines Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Preventive Vaccines Value Chain Analysis
  2. 12.1.1 Preventive Vaccines Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Preventive Vaccines Production Mode & Process
  7. 12.2 Preventive Vaccines Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Preventive Vaccines Distributors
  10. 12.2.3 Preventive Vaccines Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst